This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
This overview shows Yearly Returns For Index Funds, highlighting year-by-year performance to help readers gauge volatility and plan prudent retirement investments.
17,843 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
June 2026 looked like a milestone month for Oklo, but the stock went the other way. This deep dive explains why the s...
As volatility climbs in 2026, a tax-savvy move is drawing attention: converting traditional IRAs to Roth IRAs when va...
Robinhood Just Launched Blockchain marks a bold shift for everyday investors. This guide breaks down what it means, h...
A fresh institutional stake has emerged in Victoria’s Secret stock this quarter. The $8.5 million bet suggests some m...
A fresh look at how large holders deploy a bitcoin giant strategy and why Coinbase finds itself among the most shorte...
Andreessen Horowitz’s crypto arm is raising its fifth fund, aiming about $2 billion with a close planned for mid-2026...
XRP has shed about 62% from its July 2025 high and now trades near $1.35-$1.40. Analysts weigh whether the pullback c...
The Federal Reserve left its policy rate unchanged at its March 2026 meeting as inflation cools but the jobs market r...
DeFi is at a crossroads: grow or endure risk. Experts propose a defended capital metric to measure true resilience be...
Cathie Wood goes selling has people watching Ark Invest closely. This article breaks down three key trims, the reason...
Nvidia and Alphabet are leading a new era of high-growth tech. This deep dive breaks down why each company could reac...